Trillium Therapeutics Inc. (NASDAQ:TRIL, TSX:TR) is an immuno-oncology company dedicated to the discovery and development of novel and innovative cancer therapies.

EMAIL ALERTS

Email Address: *
First Name:
Mailing Lists





Powered By Q4 Web Systems 4.0.7.274